Exclusion of patients with kidney disease from cardiovascular trials

JAMA Internal Medicine

Volumn 176, Issue 1, 2016, Pages 124-125

  Ishida, Julie H ^a,b   Johansen, Kirsten L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LETTER; PATIENT SELECTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); CARDIOVASCULAR DISEASES; KIDNEY DISEASES;

CARDIOVASCULAR DISEASES; HUMANS; KIDNEY DISEASES; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84954546951     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.6403     Document Type: Letter

References (6)

1. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006; 296(11):1377-1384.
2. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006;70(11):2021-2030.
3. Konstantinidis I, Nadkarni GN, Yacoub R, et al. Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review [published online November 30, 2015]. JAMA Intern Med. doi:10.1001/jamainternmed.2015.6102.
4. Tomey MI, Winston JA. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health. Ann Glob Health. 2014;80(1):69-76.
5. Chertow GM, Normand SL, McNeil BJ. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol. 2004;15(9):2462-2468.
6. Goldenberg MM. Politics and clinical trials: the inclusion of women. P&T. 2003;28(12)791-793, 796.